deltatrials
Completed PHASE4 NCT00070707

Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)

Efficacy and Safety of Nasonex vs. Placebo in Subjects With SAR and Concomitant Asthma

Sponsor: Integrated Therapeutics Group

Conditions Asthma Rhinitis, Allergic, Seasonal
Interventions Albuterol/Salbutamol Mometasone Placebo
Updated 9 times since 2017 Last updated: Aug 16, 2024 Started: Apr 3, 2003 Primary completion: Nov 26, 2003 Completion: Nov 26, 2003

This PHASE4 trial investigates Asthma and Rhinitis, Allergic, Seasonal and is currently completed. Integrated Therapeutics Group leads this study, which shows 9 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

9 versions recorded

  1. Oct 2024 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Oct 2024 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Mar 2022 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Mar 2022 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Aug 2019 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Terminated → Completed

  2. Jun 2018 — Aug 2019 [monthly]

    Terminated PHASE4

  3. Apr 2017 — Jun 2018 [monthly]

    Terminated PHASE4

  4. Jan 2017 — Apr 2017 [monthly]

    Terminated PHASE4

    First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Integrated Therapeutics Group
  • Organon and Co
Data source: Organon and Co

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.